Varex Imaging Corporation
NASDAQ:VREXMedical - Devices
+$0.34 today
- Market cap
- $770.71M
- Beta
- 0.90
- P/E (TTM)
- -5.3
- EPS (TTM)
- -$1.97
Volume 0.73M
Average 0.36M
VREX EPS (Basic)
Net income attributable to common shareholders divided by the weighted average basic shares outstanding.
Varex Imaging CorporationNASDAQ: VREX
EPS (Basic) · Q2 FY2026 · quarter ended Apr 2026
EPS (Basic) turns negative
Q2 FY2026 EPS (Basic) was -$0.19, compared with $0.17 a year earlier. Trailing-twelve-month EPS (Basic) was -$1.99.
Context
- EPS (Basic) increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether EPS (Basic) reaches the consensus estimate from 2 analysts of $0.84 (+149.4%) for the fiscal year ending Oct 2026, a step up from the -45.3% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterApr 2026
- -$0.19-445.5% QoQ
- Last fiscal yearOct 2025
- -$1.7-45.3% YoY
- LTMApr 2026
- -$1.99-93.1% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -211.8% | +109.8% | +321.5 pp |
| 1 year | -45.3% | +149.4% | +194.7 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EPS (Basic) history
USD · from the income statement
- Latest · FY2025
- (1.70) USD
- Year-over-year change
- -45.3%
| Period | Period end | EPS (Basic) | YoY change |
|---|---|---|---|
| FY2025 | 2025-10-03 | (1.70) | -45.3% |
| FY2024 | 2024-09-27 | (1.17) | -197.5% |
| FY2023 | 2023-09-29 | 1.20 | +57.9% |
| FY2022 | 2022-09-30 | 0.76 | +72.7% |
| FY2021 | 2021-10-01 | 0.44 | — |
EPS (Basic) vs competitors
How VREX compares with its peers on the latest reported figures
- VREX's LTM Apr 2026 EPS (Basic) of -$1.99 is the lowest of the 5 companies compared; the peer median is $1.39.
- Its year-over-year change of -93.1% is the 4th highest of 5, against a peer median of -28.4%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Jun 2026 | $9.24 | +4.9% | +18.0% | |
| LTM Jun 2026 | $3.48 | -29.0% | +2.6% | |
| LTM Jun 2026 | -$0.7 | -234.4% | — | |
| LTM Dec 2025 | -$1.15 | -27.8% | — | |
| LTM Apr 2026 | -$1.99 | -93.1% | — | |
| Peer median (excluding VREX) | $1.39 | -28.4% | +10.3% | |
Competitors are the stored peer set for VREX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Oct 2021 | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Oct 2025 |
|---|---|---|---|---|---|
| Revenue | 818.1M | 859.4M | 893.4M | 811M | 844.6M |
| Cost of Revenue | 546.6M | 575.9M | 603.1M | 554.1M | 554.1M |
| Gross Profit | 271.5M | 283.5M | 290.3M | 256.9M | 290.5M |
| Gross Margin | 33.2% | 33.0% | 32.5% | 31.7% | 34.4% |
| Research & Development | 71.9M | 77M | 84.8M | 87M | 91.1M |
| Selling, General & Admin | 125.5M | 118.3M | 128.4M | 137.8M | 133.3M |
| Operating Expenses | 197.4M | 195.3M | 213.2M | 224.8M | 318.3M |
| Depreciation & Amortization | 37.3M | 33.6M | 33.2M | 31.1M | 27.2M |
| EBITDA | 104.5M | 114.5M | 94.7M | 62.9M | 3.5M |
| EBITDA Margin | 12.8% | 13.3% | 10.6% | 7.8% | 0.4% |
| Operating Income | 74.1M | 88.2M | 77.1M | 32.1M | (27.8M) |
| Operating Margin | 9.1% | 10.3% | 8.6% | 4.0% | -3.3% |
| Interest Income | 100K | 400K | 3.7M | 7.3M | 8.5M |
| Interest Expense | 43.4M | 41M | 29.3M | 31.1M | 35.5M |
| Other Income / Expenses | (45.5M) | (43.7M) | (45.8M) | (27.1M) | (31.4M) |
| Income Before Tax | 28.6M | 44.5M | 31.3M | 5M | (59.2M) |
| Pre-Tax Margin | 3.5% | 5.2% | 3.5% | 0.6% | -7.0% |
| Income Tax Expense | 10.7M | 13.7M | (16.6M) | 52.2M | 10.7M |
| Net Income | 17.4M | 30.3M | 47.4M | (47.7M) | (70.3M) |
| Net Margin | 2.1% | 3.5% | 5.3% | -5.9% | -8.3% |
| EPS (Basic) | 0.44 | 0.76 | 1.20 | (1.17) | (1.70) |
| EPS (Diluted) | 0.43 | 0.73 | 0.96 | (1.17) | (1.70) |
| Weighted Avg Shares | 39.3M | 39.8M | 40.3M | 40.8M | 41.4M |
| Weighted Avg Shares (Diluted) | 40.3M | 41.6M | 50.3M | 40.8M | 41.4M |
Varex Imaging Corporation
NASDAQ:VREX
Intrinsic Alpha fair value
Locked
Current Price
$18.15
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.